SelectQuote Projects Revenue and Adjusted EBITDA for FY25, Exceeding Consensus Estimates
AinvestTuesday, Nov 5, 2024 8:11 am ET
1min readSelectQuote anticipates FY25 revenue between $1.425 billion and $1.525 billion, slightly exceeding the consensus estimate of $1.44 billion. The company also projects Adjusted EBITDA to fall within a range of $100 million to $130 million for the same fiscal year. The announcement follows SelectQuote's Q1 EPS report, which outperformed consensus expectations.
SelectQuote, Inc. (NYSE: SLQT) reported a robust first quarter of fiscal year 2025, with revenue growth and improved performance metrics that surpassed expectations. This encouraging start has set the stage for the company's anticipated full-year revenue and earnings.In the first quarter of FY25, SelectQuote generated consolidated revenue of $292.3 million, representing a 26.5% year-over-year increase from the $232.7 million reported in the same period last year (1). The company's net loss for the quarter narrowed to $44.5 million from the $31.1 million reported in Q1 FY24. Most notably, consolidated Adjusted EBITDA* improved to a loss of $(1.7) million compared to a loss of $(11.4) million in the prior-year quarter (1).
SelectQuote's CEO, Tim Danker, attributed the strong performance to the company's holistic approach to healthcare connectivity, which has become increasingly valuable as benefit coverage for Medicare Advantage plans underwent significant shifts this season (1). Both seniors and insurance carriers have turned to SelectQuote's agent-led, true-choice platform to ensure individual care needs are met with the best available plans.
Moreover, the company's Healthcare Services platform, led by SelectRx, experienced notable growth. SelectRx now boasts over 86,500 members, demonstrating the appeal of its bespoke prescription drug service (1).
Looking ahead, SelectQuote anticipates full-year revenue between $1.425 billion and $1.525 billion, slightly exceeding the consensus estimate of $1.44 billion (2). The company also projects Adjusted EBITDA to fall within a range of $100 million to $130 million for the same fiscal year (2).
These projections reflect the company's continued growth trajectory, driven by its expanding healthcare services offerings and the increasing demand for its agent-led platform in the evolving healthcare landscape.
References:
[1] Business Wire. (2024, November 4). SelectQuote, Inc. Reports First Quarter of Fiscal Year 2025 Results. Retrieved from https://www.businesswire.com/news/home/20241104387638/en/SelectQuote-Inc.-Reports-First-Quarter-of-Fiscal-Year-2025-Results
[2] Seeking Alpha. (2024, November 4). SelectQuote Inc. (SLQT) Q1 2025 Earnings Call Transcript. Retrieved from https://seekingalpha.com/news/3850739-selectquotes-inc-slqt-q1-2025-earnings-call-transcript?source=email_article
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
Comments
No comments yet